U.S. Diversified Financial Stock News

Guardant Health (GH) has seen its stock climb in recent months, gaining steam as a result of growing investor interest and strong momentum in health technology equities. Recent performance trends are catching many investors’ attention as the conversation shifts to valuation. See our latest analysis for Guardant Health. Guardant Health's share price has more than doubled year-to-date, delivering a 123% share price return, as excitement builds around its technology and progress in the health...

Wondering what to do with Ventas stock? You are not alone. Over the past year, Ventas has caught the attention of investors, with its share price climbing 13.8% and a striking 23.4% rally year-to-date. If you zoom out even further, the five-year gain of 107.9% makes it hard to ignore for anyone building a portfolio for long-term growth. Even though the latest seven-day return is just 0.1%, that is not unusual after periods of strong performance, and many investors are watching closely to see...

Thinking about what to do with your L3Harris Technologies stock? You are not alone. The defense and aerospace sector has been dynamic lately, and L3Harris is right in the thick of it. After a remarkable 40.4% rise year-to-date, it is easy to wonder whether the momentum can continue or if things are about to hit a plateau. A quick glance at the numbers shows the stock edged up 0.2% this past week, while the past month was slightly in the red at -0.8%. Longer-term investors, though, have seen...

Easterly Government Properties (DEA) is forecasting revenue growth of 6.4% per year, which trails the US market's average of 10.1%. Earnings are expected to inch up by 2.4% annually, also lagging the market average of 15.5%. After a year of negative earnings growth and a slip in net profit margins from 6.2% to 5.2%, investors will be weighing the significance of muted growth forecasts, elevated valuation multiples, and ongoing financial risks as the company's earnings results come into...

Following the September inflation report, mortgage rates were set to move lower, sparking renewed activity in mortgage originators and home construction firms. This shift in the interest rate outlook holds particular significance for mortgage-focused businesses such as Rocket Companies, which are closely linked to housing market conditions. With mortgage rates projected to ease, we'll explore how this potential tailwind could influence Rocket Companies' investment appeal amid ongoing housing...

Datadog (DDOG) shares have shown steady gains over the month, climbing about 13%. Investors have taken notice of this performance, as many are weighing the company’s growth prospects while cloud adoption continues to shape the software landscape. See our latest analysis for Datadog. Datadog’s share price has been on a steady upward trajectory, with a 13.3% jump over the past month helping the company recapture momentum after a more modest start to the year. Looking at a broader timeframe, the...

Thinking about what to do next with MGM Resorts International stock? You are not alone. Investors have been watching MGM’s price swings closely, trying to decide whether this is a classic value opportunity or just a rebound story with baggage. Over the past week, the stock inched up 3.3%, hinting at renewed market optimism after a rocky patch. Still, MGM’s 1-year return stands at -21.1%, and it has underperformed over both the 3-year and year-to-date periods. What is behind this tug-of-war...

TG Therapeutics recently announced the completion of enrollment in the randomized cohort of its Phase 3 ENHANCE trial investigating a consolidated Day 1 and Day 15 dosing schedule for IV BRIUMVI in patients with relapsing forms of multiple sclerosis. This milestone brings the company closer to potentially offering a more convenient single-infusion regimen, which could differentiate BRIUMVI in the competitive multiple sclerosis treatment landscape. We'll now examine how advancing a...

Trinity Energy announced it has partnered with JinkoSolar to supply around 1,000 EAGLE G6 solar modules for a Costco Warehouse in Richland, Washington, with the project participating in the EAGLE Preserve recycling program. This marks Washington State's first approved solar stewardship initiative, ensuring sustainable recycling for end-of-life modules at no cost to Costco or Trinity Energy. We'll explore how JinkoSolar's leadership in solar sustainability with EAGLE Preserve could influence...

Park National (PRK) has caught the eye of some investors recently, as returns have trended lower over the month with the stock down 5%. Its longer-term track record, however, remains a point of interest. See our latest analysis for Park National. The recent 5% dip in Park National’s share price over the past month comes after a period of quiet for the company, but the bigger story is in the numbers. While 2024 has started with softer momentum, Park’s 3-year total shareholder return is up...

Thinking about what to do with Western Union stock right now? You’re not alone. After all, there’s something about a financial company with a long history and a cheap-looking share price that makes investors wonder if it just might be ready to turn the page. Over the past month, Western Union has posted a strong double-digit climb of 12.1%, with a 10.0% bump just in the past week. That kind of momentum stands out, especially considering the stock is still off 14.7% year-to-date and down even...

Axalta Coating Systems recently reported third-quarter 2025 earnings, posting net income of US$110 million and diluted earnings per share of US$0.51, alongside updated full-year guidance projecting net sales to exceed US$5.1 billion. Despite a slight year-over-year drop in quarterly and nine-month sales, the company achieved higher net income and earnings per share, reflecting strengthened profitability and operational efficiency. We'll explore how Axalta's improved earnings and upgraded...

Are you staring at Berkshire Hathaway stock and wondering if now is the right time to buy, sell, or simply hold tight? You are definitely not alone. With its reputation as the ultimate blue-chip play and a five-year return of 139.1%, this stock continues to attract both seasoned investors and newcomers alike. But even stocks backed by Warren Buffett can experience bumps in the road. Over the past month, Berkshire's share price dipped 2.3%, while the most recent week saw a more modest slide of...

Tenet Healthcare posted third-quarter results that came in ahead of expectations, with both revenue and earnings beating forecasts. The company also nudged its full-year guidance higher, reinforcing optimism for the rest of 2025. See our latest analysis for Tenet Healthcare. Tenet Healthcare’s upbeat results and raised outlook appear to have fueled strong momentum in the shares, with a 2.75% gain on results day and a 7% share price return in just the past month. Looking at a broader...

Eaton (ETN) has just expanded its distribution agreements with both Satair and Proponent, which opens new doors in the commercial aftermarket space. These moves aim to give operators broader and more dependable access to Eaton’s fuel and actuation components worldwide. See our latest analysis for Eaton. Eaton’s recent distribution expansions come after a strong run, with the 1-year total shareholder return at 11.3% and a significant 165% gain over the past three years. After a slight dip in...

In October 2025, Rexford Industrial Realty reported robust third-quarter and nine-month financial results, raised full-year 2025 earnings guidance, authorized a new US$500 million share repurchase program, and affirmed both common and preferred dividends. A unique development is Rexford's rapid execution of share repurchases in recent months following new buyback authorizations, reflecting a pronounced focus on capital return alongside improved operational performance. We’ll examine how the...

Target is making headlines after announcing its largest corporate workforce reduction in a decade by eliminating about 8% of its headquarters staff. The move, led by incoming CEO Michael Fiddelke, signals a renewed focus on streamlining operations and adapting to a competitive retail landscape. See our latest analysis for Target. Target's announcement comes on the heels of a tough year, with its share price down nearly 29% year-to-date and a one-year total shareholder return of -31%. While...

Planet Fitness was recognized on Fortune's 2025 100 Fastest-Growing Companies list, following multi-year growth in revenue, earnings, and club expansion, and the company recently announced a multi-year partnership with Hockey Canada to engage Canadian communities through fitness initiatives tied to hockey culture. This collaboration highlights Planet Fitness's drive to broaden its reach by connecting with new member segments and leveraging sports partnerships to reinforce its...

TeraWulf Inc. recently announced it has entered a long-term joint venture with Fluidstack to develop 168 MW of high-performance computing infrastructure at its Abernathy, Texas campus, underpinned by a 25-year, US$9.5 billion contracted revenue commitment and lease support backed by Google. This partnership significantly accelerates TeraWulf’s shift towards artificial intelligence and high-performance computing, with exclusive rights to partner on future Fluidstack-led projects and over...

Earlier this month, analysts reiterated strong confidence in Innovative Industrial Properties thanks to its robust financial position and double-digit yield, despite near-term risks such as tenant defaults and possible dividend reductions. At the same time, a legal battle began on October 20 regarding access to Florida's regulated medical cannabis market, which could create new opportunities for companies following IIPR's specialized real estate model. We'll explore how growing optimism...

Kiniksa Pharmaceuticals (KNSA) posted impressive third quarter results, as ARCALYST net product revenue jumped 61% compared to last year and the company swung to profitability. Management also raised their full-year ARCALYST revenue guidance. See our latest analysis for Kiniksa Pharmaceuticals International. Momentum has been steadily building for Kiniksa Pharmaceuticals International, with the stock rising 11.3% over the past month and 33.7% in the last 90 days as upbeat ARCALYST revenues...

In the past week, regional bank shares including The Bancorp moved higher after a cooler-than-expected inflation report raised expectations for possible Federal Reserve interest rate cuts. This shift in sentiment reflects growing confidence that lower funding costs and increased loan demand could benefit banks if rates are reduced. The likely impact of potential interest rate cuts on funding costs is a key factor to consider when assessing Bancorp's investment outlook. We’ll now explore how...

If you find yourself thinking about what to do with Kenvue stock right now, you are not alone. After all, it is tough to ignore a stock that has seen both volatility and fresh headlines lately. In just the past week, Kenvue returned 0.8%, yet that barely makes a dent in the big picture: over the past month, shares have slid -8.2%, and the year-to-date drop sits at a hefty -29.1%. Stretch that out to a year, and Kenvue is down -31.6%, making some investors wonder whether the recent declines...

Ardelyx (ARDX) shares have seen some volatility recently, and investors are watching for developments that could offer clarity on the company's outlook. The stock's recent performance shows mixed signals. This has prompted deeper analysis. See our latest analysis for Ardelyx. After a sharp rally earlier in the year, Ardelyx's share price momentum has slowed. The stock is now sitting at $5.10 and has posted a 20.85% gain over the last 90 days. However, the one-year total shareholder return is...